Perimeter Medical Imaging AI Announces Follow-On Commercial Placement of Perimeter S-Series OCT
Perimeter Medical Imaging AI, announced another commercial placement of its flagship Perimeter S-Series OCT system at a second hospital within one of the largest healthcare networks in North Texas, which is part of a major national healthcare system. Perimeter is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs.
Latest NaturalAI Insights: InspireXT Announces Acquisition Of NaturalAI – A Conversational Artificial Intelligence Platform To Expand Its Solution Portfolio
Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “Approximately six weeks ago, we announced the commercial placement of our Perimeter S-Series OCT system within a national healthcare network. I am pleased to report that we have now completed the second commercial installation at another hospital within this major healthcare system. This further validates a core part of our commercial strategy as we expand use within key integrated delivery network customers. Further, we are receiving timely, positive feedback that the value provided by our technology is resonating with not only our end-users but other stakeholders within the healthcare system as well.”
AI News: Infobip Creates AI-powered Chatbot for Uber
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level, with 10x greater image resolution than X-ray and ultrasound, and 100x greater than MRI. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company’s ticker symbol “PINK” is a reference to the pink ribbons displayed during Breast Cancer Awareness Month.
Latest Aithority Insights : NVIDIA Raises the Standard of Low Code DevOps with the NVIDIA AI Enterprise 2.1
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.